HER2-Positive Breast CA Patients Prosper on Solo Chemo

Options
besa
besa Member Posts: 1,088
edited October 2015 in Clinical Trials, Research News, Podcasts, and Study Results

http://www.medpagetoday.com/HematologyOncology/Bre...

"Patients with elevated tumor-infiltrating lymphocytes do better without additional Herceptin"


"Action points-

  • Note that this retrospective analysis of a clinical trial revealed that women with HER-2 positive breast cancer did not benefit from adjuvant Herceptin in the presence of stromal tumor-infiltrating lymphocytes.
  • Be aware that these findings run counter to a prior study that found essentially the opposite relationship."
· Share on FacebookShare on Twitter

Categories